Oncolytics Biotech Stocks List

Related Stock Lists: Biopharmaceutical Cancer Cancer Therapeutics Cancer Therapy Chemical Compounds Chemistry Johnson & Johnson Metastatic Colorectal Cancer Ovarian Cancer Prostate Cancer RTT Solid Tumors Targeted Therapy Treating Cancer Treatment Of Cancer Treatment Of Ovarian Cancer
Related Industries: Biotechnology Other

Recent Signals

Date Stock Signal Type
2020-05-29 ONCX Narrow Range Bar Range Contraction
2020-05-29 ONCX Stochastic Buy Signal Bullish
2020-05-29 ONCX Expansion Breakout Bullish Swing Setup
2020-05-29 ONCX Expansion Breakdown Bearish Swing Setup
2020-05-29 ONCX Jack-in-the-Box Bearish Bearish Swing Setup
2020-05-29 ONCX Jack-in-the-Box Bullish Bullish Swing Setup

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called REOLYSIN® for the treatment of solid tumors and hematological malignancies. REOLYSIN is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

More about Oncolytics Biotech